The re-adjustment of the health insurance catalogue has allowed people's livelihood and welfare to rise rapidly

On December 28th, the State Administration of Medical Security and the Ministry of Human Resources and Social Security published the National List of Medicines for Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance (2020), which will come into effect on March 1 next year.
2800 kinds of drugs in the catalogue, of which 1426 are Western medicine and 1374 are Chinese medicine.
chinese medicine tablets have not been adjusted, still 892 kinds.
the current adjustment, 162 drugs were negotiated, 119 successful, including 96 exclusive drugs, with a success rate of 73.46 per cent.
price of drugs negotiated successfully has fallen by more than half.
(see 08 edition of relevant reports) According to experts, the 2020 national health care catalog adjustment set the largest number of drugs negotiated, the new finalists in the price reduction and clinical effect achieved a "higher cost-effective."
of this adjustment is that the interval from the previous adjustment is significantly shorter.
since the first edition of China's national medical insurance drug catalogue was formulated in 2000, it has been adjusted in 2004, 2009 and 2017, with adjustment intervals of up to 8 years from 2009 to 2017.
has since made an adjustment in 2019 and a year later.
from eight years apart to a year apart, the pace of adjustment has surprised many in the industry.
This is due to the "Interim Measures for the Administration of Drug Use in Basic Medical Insurance" issued by the State Health Insurance Administration on July 30 this year, article 11 of which stipulates that the administrative department of medical security under the State Council shall establish and improve the mechanism of dynamic adjustment, which shall, in principle, be adjusted annually.
, this fast-paced adjustment will become the norm.
fast-paced adjustment of the medical insurance drug catalog is a major good for innovative and clinically essential drugs.
the past, such good medicine is difficult to look forward to the opportunity to adjust the medical insurance drug catalog, many can only be "raised in the deep unknown."
, pharmaceutical companies don't worry about being buried as long as they have good medicine in their hands.
fast-paced adjustment of china's medical insurance drug catalogue is conducive to promoting pharmaceutical companies to increase investment in research and development, focus on innovation and development, and strive to achieve high-quality and low-priced competitive advantage.
drug companies that still refuse to give up old practices such as gold sales are bound to be punished by the market and will eventually be eliminated.
the pace of adjustment, the Medicare drug catalog will no longer be a "safe deposit box."
Interim Measures for the Administration of Drug Use in Basic Medical Insurance clearly stipulate that medicines that are guaranteed priority for medical insurance, and non-essential drugs such as medicines and health care drugs, which mainly play a tonic role, will no longer be included in the catalogue.
past, there have been many auxiliary drugs in the catalog for a long time "occupying the pit", resulting in many patients eagerly await the clinically necessary good drugs difficult to enter the catalog.
the dynamic adjustment of the medical insurance drug catalog, the pace of drug addition and transfer out of the catalog will accelerate, will enable more patients to bid farewell to the history of "hope medicine."
this adjustment, is a rapid adjustment, dynamic adjustment of the first time, but also let the watchers, skeptics eat the heart."
In this way, pharmaceutical companies need to speed up drug innovation and research and development, doctors prescribe will also reduce a lot of concerns, and the public benefits from a variety of benefits: not only to be able to use the drugs that are really needed, but also to obtain low-cost benefits, on the basis of which they can be reimbursed proportionally.
these benefits together will give Medicare a rapid boost to people's well-being.
in the recent drug bargaining negotiations, not only frequent "soul cut prices", many drugs also appeared the world's lowest price.
China has the largest health care network, but also the largest population base, according to market price relations, in negotiations with multinational pharmaceutical companies, we have enough bottom gas to obtain the lowest prices in the world.
, in recent years, the state has introduced many major reforms, including the abolition of drug additions and the introduction of centralized drug collection, which have also rationalize the order of the drug market.
of these factors determine that the rapid rise in health care and people's livelihood benefits will continue.
the quality of medicines is getting higher and higher, the price of medicines is getting cheaper, and the burden of patients seeing a doctor is becoming less and less, which will become an inevitable trend.